These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1028819)

  • 21. High blood glucose and osmolality, but not high urinary glucose and osmolality, affect neuronal nitric oxide synthase expression in diabetic rat kidney.
    Hsieh MC; Wu CH; Chen CL; Chen HC; Chang CC; Shin SJ
    J Lab Clin Med; 2003 Mar; 141(3):200-9. PubMed ID: 12624601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Transport processes--ultrafiltration in peritoneal dialysis].
    Nesić V; Dimitrijević Z; Stojimirović B
    Srp Arh Celok Lek; 1996; 124 Suppl 1():159-62. PubMed ID: 9102889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The free cortisol index in renal disease.
    Brien TG
    J Nucl Med Allied Sci; 1980; 24(3-4):139-43. PubMed ID: 7252576
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide?
    Douma CE; de Waart DR; Struijk DG; Krediet RT
    Clin Nephrol; 1996 May; 45(5):295-302. PubMed ID: 8738660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of hemodialysis on protein synthesis.
    Löfberg E; Essén P; McNurlan M; Wernerman J; Garlick P; Anderstam B; Bergström J; Alvestrand A
    Clin Nephrol; 2000 Oct; 54(4):284-94. PubMed ID: 11076104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Basal gastrin content of the blood in kidney diseases].
    Ryss ES; Riabov SI; Lutoshkin MB
    Klin Med (Mosk); 1985 Jan; 63(1):95-9. PubMed ID: 3990196
    [No Abstract]   [Full Text] [Related]  

  • 27. Neutral-pH peritoneal dialysis solution improves peritoneal function and decreases matrix metalloproteinase-2 (MMP-2) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Nishina M; Endoh M; Suzuki D; Tanabe R; Endoh H; Hirahara I; Sakai H
    Clin Exp Nephrol; 2004 Dec; 8(4):339-43. PubMed ID: 15619033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of low dialysate sodium and glucose concentration on volume distributions in body compartments after haemodialysis: a bioimpedance analysis study.
    Ozturk S; Taymez DG; Bahat G; Demirel R; Yazici H; Aysuna N; Sakar S; Yildiz A
    Nephrol Dial Transplant; 2008 Nov; 23(11):3629-34. PubMed ID: 18508835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Modification of osmolality with I.V. mannitol and/or high glucose concentration in the bath during hemodialysis (author's transl)].
    Munzenmayer J; Vaccareza A; Vial S; Pineda L; Parada I; Chacón C; Tobar MC; Boggiano G
    Rev Med Chil; 1981 Dec; 109(12):1177-84. PubMed ID: 6810433
    [No Abstract]   [Full Text] [Related]  

  • 30. Can we improve the quality of life for dialysis patients?
    Kliger AS; Finkelstein FO
    Am J Kidney Dis; 2009 Dec; 54(6):993-5. PubMed ID: 19932876
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of adding Br or Zn supplements to the dialysate on the concentrations of Br and Zn in the blood of hemodialysed patients.
    Van Renterghem D; Cornelis R; Mees L; Vanholder R
    J Trace Elem Electrolytes Health Dis; 1992 Jun; 6(2):105-9. PubMed ID: 1422178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the effects of an isosmolar and hyperosmolar oral rehydrating solution on the hydration status, glycemia and ileal content composition of healthy neonatal calves.
    Levy M; Merritt AM; Levy LC
    Cornell Vet; 1990 Apr; 80(2):143-51. PubMed ID: 2318040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma insulin is removed by hemodialysis: evaluation of the relation between plasma insulin and glucose by using a dialysate with or without glucose.
    Abe M; Kaizu K; Matsumoto K
    Ther Apher Dial; 2007 Aug; 11(4):280-7. PubMed ID: 17661834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of glucose added to the dialysis fluid on blood pressure, blood glucose, and quality of life in hemodialysis patients: a placebo-controlled crossover study.
    Sangill M; Pedersen EB
    Am J Kidney Dis; 2006 Apr; 47(4):636-43. PubMed ID: 16564941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma cystatin C for estimating residual GFR (rGFR) in dialysis patients.
    Tidman M; Sjöström P; Jones I
    Nephrol Dial Transplant; 2008 Mar; 23(3):1072-3; author reply 1073. PubMed ID: 17984103
    [No Abstract]   [Full Text] [Related]  

  • 36. Hemoglobin level in dialysis patients: revisiting the normal hematocrit study.
    Singh AK
    Kidney Int; 2007 Nov; 72(9):1161; author reply 1161-2. PubMed ID: 17943155
    [No Abstract]   [Full Text] [Related]  

  • 37. Intraocular pressure during hemodialysis.
    Broekema N; van Bijsterveld OP; de Bos Kuil RJ
    Ophthalmologica; 1988; 197(2):60-4. PubMed ID: 3186209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoprotein(a) concentration in patients with renal diseases.
    Elisaf M; Siamopoulos KC
    Am J Kidney Dis; 1996 Aug; 28(2):307. PubMed ID: 8768931
    [No Abstract]   [Full Text] [Related]  

  • 39. Balance between pro-inflammatory cytokines and their specific inhibitors in patients on dialysis.
    Pereira BJ
    Nephrol Dial Transplant; 1995; 10 Suppl 7():27-32. PubMed ID: 8570075
    [No Abstract]   [Full Text] [Related]  

  • 40. Letter: Blood-lipids in renal disease.
    Roodvoets AP; Struyvenberg A
    Lancet; 1975 May; 1(7915):1091. PubMed ID: 48760
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.